商汤(00020.HK) 伙罗氏诊断推出面向IVD(体外诊断)专业场景的AI解决方案“易问e答”。该平台以商汤自研的日日新多模态大模型为技术基础,融合罗氏诊断数十年积累的专业知识,量身打造出深明IVD行业的AI助手,全面提升客户服务体验与工作效率。
商汤指,在实际应用中,该平台能够精准解读项目说明中的专业内容,为医生提供详细的诊断依据,帮助医生快速做出准确的临床决策,提供个性化的诊断建议。经专业人士对于200多条随机提问生成内容作出评估,发现“易问e答”的准确度,相比其他通用大模型高出38%。(ha/w)(港股报价延迟最少十五分钟。沽空资料截至 2025-06-26 16:25。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.